Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NewGenIvf Group ( (NIVF) ) just unveiled an announcement.
On February 13, 2026, NewGenIvf Group’s board approved a one-for-four reverse stock split of all issued and unissued shares, covering Class A and Class B ordinary shares and preferred shares, without requiring shareholder approval under BVI law. The move takes effect at 12:01 a.m. ET on March 16, 2026, when the Class A shares will begin trading on Nasdaq on a split-adjusted basis under a new CUSIP, reducing outstanding Class A shares from 2,273,790 to about 568,323 and eliminating fractional shares through rounding up to whole shares.
Following the reverse split, all outstanding options, warrants and other convertible securities will be proportionally adjusted by a factor of four, with resulting figures rounded to the nearest whole share. The transaction does not change par value, which remains nil, nor the company’s unlimited authorized share capital, signaling a purely structural capital adjustment aimed at consolidating the share count without altering the underlying economic rights of existing stakeholders.
More about NewGenIvf Group
NewGenIvf Group Limited is a foreign private issuer listed on the Nasdaq Capital Market under the symbol NIVF. The company is incorporated in the British Virgin Islands and is headquartered in Bangkok, Thailand, positioning it within the global capital markets as an overseas-listed issuer rather than a U.S.-domiciled firm.
Average Trading Volume: 617,973
Technical Sentiment Signal: Sell
Current Market Cap: $1.26M
See more data about NIVF stock on TipRanks’ Stock Analysis page.